Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/3235
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Saad, F. | - |
dc.contributor.author | Armstrong, A. J. | - |
dc.contributor.author | Thiery-Vuillemin, A. | - |
dc.contributor.author | Oya, M. | - |
dc.contributor.author | Shore, N. D. | - |
dc.contributor.author | Procopio, G. | - |
dc.contributor.author | Arslan, C. | - |
dc.date.accessioned | 2023-06-16T14:56:45Z | - |
dc.date.available | 2023-06-16T14:56:45Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.issn | 1569-8041 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.14365/3235 | - |
dc.description | Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- SEP 09-13, 2022 -- ELECTR NETWORK | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Soc Med Oncol | en_US |
dc.description.sponsorship | AstraZeneca; Merck Sharp Dohme LLC | en_US |
dc.description.sponsorship | AstraZeneca and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Annals of Oncology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) | en_US |
dc.type | Conference Object | en_US |
dc.department | İzmir Ekonomi Üniversitesi | en_US |
dc.identifier.volume | 33 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.startpage | S1160 | en_US |
dc.identifier.endpage | S1160 | en_US |
dc.identifier.wos | WOS:000866211601614 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopusquality | Q1 | - |
dc.identifier.wosquality | Q1 | - |
item.grantfulltext | reserved | - |
item.openairetype | Conference Object | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 09.02. Internal Sciences | - |
Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
2340.pdf Restricted Access | 157.18 kB | Adobe PDF | View/Open Request a copy |
CORE Recommender
WEB OF SCIENCETM
Citations
6
checked on Nov 20, 2024
Page view(s)
50
checked on Nov 18, 2024
Download(s)
6
checked on Nov 18, 2024
Google ScholarTM
Check
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.